[1]王文娟,陶利利,刘杰,等.补肾活血周期疗法联合淋巴细胞主动免疫治疗同种免疫性复发性流产疗效及对患者血清封闭抗体的影响*[J].陕西中医,2018,(11):1573-1575,1579.
 Wang Wenjuan,Tao Lili,Liu Jie,et al.The effect of Bushen Huoxue therapy combined lymphocyte active immunotherapy on immunological recurrent abortion and its effect on serum related antibodies[J].,2018,(11):1573-1575,1579.
点击复制

补肾活血周期疗法联合淋巴细胞主动免疫治疗同种免疫性复发性流产疗效及对患者血清封闭抗体的影响*
分享到:

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2018年11期
页码:
1573-1575,1579
栏目:
临床研究
出版日期:
2018-12-31

文章信息/Info

Title:
The effect of Bushen Huoxue therapy combined lymphocyte active immunotherapy on immunological recurrent abortion and its effect on serum related antibodies
文章编号:
10.3969/j.issn.1000-7369.2018.11.024
作者:
王文娟陶利利刘杰卢宗林
河南省洛阳市第一中医院生殖医学科 (洛阳 471000 )
Author(s):
Wang WenjuanTao LiliLiu Jieet al.
Department of Reproductive Medicine, The First Hospital of Traditional Chinese Medicine in Luoyang(Luoyang 471000 )
关键词:
流产/中西医结合疗法@补肾活血周期疗法
Keywords:
Abortion/integratedChinese traditional and western medicine therapy@Bushen Huoxue therapy
分类号:
R714.21
文献标志码:
A
摘要:
目的:观察补肾活血周期疗法联合淋巴细胞主动免疫治疗免疫性复发性流产的疗效及对血清封闭抗体(BA)的影响。方法:选取102例免疫性复发性流产患者作为研究资料。将入选患者分为对照组与研究组,对照组采取单纯淋巴细胞主动免疫治疗,研究组在采用对照组治疗方法的同时,应用中医补肾活血周期疗法,治疗至患者妊娠12周时停止,对比两组患者妊娠结局;观察两组封闭抗体阳性率、封闭抗体转阳时间;观察治疗前后两组患者淋巴细胞免疫表型的变化情况。结果:〖JP2〗研究组BA阳性率高于对照组(P<0.05);研究组妊娠结局整体情况优于对照组(P<0.05);研究组治疗后BA转阳时间较对照组短(P<0.05)。治疗后两组各项淋巴细胞免疫表型均较治疗前改善(P<0.05);但研究组CD3+T、CD4+T、CD4+THLA-DR+/CD4+、CD3-CD56+NK、CD4+TCD25+CD127dimTreg均优于对照组(P<0.05)。结论:补肾活血周期疗法联合淋巴细胞主动免疫治疗,能够缩短封闭抗体转阳时间,提高封闭抗体阳性率与免疫表型的表达水平,有效改善妊娠结局。
Abstract:
Objective: Explore the therapeutic effect of Bushen Huoxue therapy combined with active lymphocyte immunization in the treatment of recurrent immunological abortion and its effect on serum closed antibody (BA).Methods: 102 patients with recurrent immunological abortion admitted were selected as the study data. To selected patients were divided into control group and research group, control group take the pure lymphocyte immune treatment actively, the team in the control group treatment method at the same time, the application of traditional Chinese medicine Bushen Huoxue therapy of treatment, the treatment to the patients with pregnancy stop at 12 weeks, compared two groups of patients with pregnancy outcome; the positive rate of the closed antibody and the time of the closed antibody were observed. The changes of lymphocyte immunophenotype before and after treatment were observed. Results: The positive rate of BA in the study group was higher than that in the control group(P<0.05). The overall pregnancy outcome of the study group was better than that of the control group(P<0.05). Compared with the control group, the time of BA was shorter after treatment(P<0.05). After treatment, all lymphocyte immunopheno types of the two groups were improved(P<0.05). However, CD3+T、CD4+T、CD4+THLA-DR+/CD4+、CD3-CD56+NK、CD4+TCD25+CD127dimTreg in the study group were better than those in the control group(P<0.05). Conclusion:Bushen Huoxue therapy combined with the active immunotherapy of lymphocyte, can shorten the time of closing antibody to positive, and improve the positive rate of closed antibody and the expression level of immunophenotype.

参考文献/References:

[1]Jabez CJ, Khanna NH, Kannan A. A clinical decision support system for diagnosis of Allergic Rhinitis based on intradermal skin tests [J]. Comput Biol Med, 2015, 65:76-84.
[2]Sritipsukho P, Satdhabudha A, Nanthapisal S. Effect of allergic rhinitis and asthma on the quality of life in young Thai adolescents [J]. Asian Pac J Allergy Immunol, 2015, 33(3):222-226.
[3]Hafez MR, Abu-Bakr SM, Mohamed AA. Forced oscillometry track sites of airway obstruction in bronchial asthma [J]. Ann Allergy Asthma Immunol, 2015, 115(1):28-32.
[4]孙慧媛, 孙瑞华, 张秀艳, 等. 基于临床流行病学的支气管哮喘慢性持续期证候特征研究 [J]. 中华中医药杂志, 2016, 31(11): 4494-4498.
[5]中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南 (2016年版) [J]. 中华结核和呼吸杂志, 2016,39(9): 675-697.
[6]程延彬,于欢庆. 中医治疗哮喘的方法及临床价值评估与分析[J].中西医结合心血管病电子杂志, 2017, 5 (27):143-144.
[7]中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童支气管哮喘诊断与防治指南 (2016 年版) [J]. 中华儿科杂志, 2016, 54(3): 167-181.
[8]李建生, 王至婉. 支气管哮喘中医证候诊断标准 (2016版) [J]. 中医杂志, 2016, 57(22): 1978-1980.
[9]Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: allergic rhinitis executive summary [J]. Otolaryngol Head Neck Surg,2015, 152(2):197-206.
[10]Bateman ED, Goehring UM, Richard F, et al. Roflumilast combined with montelukast versus montelukast alone as add-on treatment in patients with moderate-to-severe asthma [J]. J Allergy Clin Immunol, 2016, 138(1):142-149.
[11]Simpson JL, Carroll M, Yang IA, et al. Reduced antiviral interferon production in poorly controlled asthma is associated with neutrophilic inflammation and high-dose inhaled corticosteroids [J]. Chest, 2016, 149(3):704-713.
[12] 顾静雯, 姜之炎. 清肺平喘方联合硫酸沙丁胺醇气雾剂治疗小儿热性哮喘证轻中度发作的临床观察 [J]. 河北中医, 2018, 40(3): 394-397.
[13]朱金凤. 支气管哮喘的中医辨治思维与方法研究 [J]. 中国中医基础医学杂志, 2016, 22(2): 284-286.
[14]陆雪莲, 张念志. 支气管哮喘中医药研究概况 [J]. 中医药临床杂志, 2017,29(11): 1783-1786.
[15]张欣, 郑心. 从营卫气血理论探讨支气管哮喘的中医药治疗 [J]. 湖北中医杂志, 2016, 38(9): 53-54.
[16]李竹英, 韩文英, 郅扶旻. 中西医结合治疗支气管哮喘急性发作研究进展 [J]. 中国中医急症, 2016, 25(3): 461-463.
[17]陈奇. 中药药理研究方法学[M]. 2版.北京: 人民卫生出版社, 2006:244-260.
[18]黄静. 清气化痰汤对小儿咳嗽变异性哮喘血清指标和诱导痰指标的影响 [J]. 海南医学院学报, 2016, 22(10): 1020-1023.
[19]Ahmadi Z, Hassanshahi G, Khorramdelazad H, et al. An overlook to the characteristics and roles played by eotaxin network in the pathophysiology of food allergies: allergic asthma and atopic dermatitis [J]. Inflammation, 2016, 39(3):1253-1267.
[20]陈太碧, 胡涛. 检测支气管哮喘患者多项指标变化的临床意义 [J]. 临床肺科杂志, 2017, 22 (5): 941-943.
[21]Rojas-Dotor S, Segura-Méndez NH, Miyagui-Namikawa K, et al. Expression of resistin, CXCR3, IP-10, CCR5 and MIP-1α in obese patients with different severity ofasthma [J]. Biol Res, 2013, 46(1): 13-20.

备注/Memo

备注/Memo:
*河南省洛阳市科学技术局科研课题(1870003A)
更新日期/Last Update: 2018-11-30